Advertisement
HCAT vs MRT
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HCAT is a Hold and MRT is a StrongBuy.
HCAT sees its 50-day moving average cross bearishly below its 200-day moving average
The 50-day moving average for HCAT moved below the 200-day moving average on October 13, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HCAT as a result. In 78 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.
The Moving Average Convergence Divergence Histogram (MACD) for HCAT turned negative on October 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 42 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HCAT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
HCAT broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for HCAT entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 48 of 64 cases where HCAT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
HCAT moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for HCAT crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.
Following a +1.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where HCAT advanced for three days, in 178 of 244 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 42 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.299) is normal, around the industry mean (3.981). P/E Ratio (-0.473) is within average values for comparable stocks, (13.628). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (0.429) is also within normal values, averaging (6.065).
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. HCAT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HCAT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.
MRT sees its 50-day moving average cross bullishly above its 200-day moving average
The 50-day moving average for MRT moved above the 200-day moving average on October 06, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on MRT as a result. In 53 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.
The Moving Average Convergence Divergence (MACD) for MRT just turned positive on October 21, 2026. Looking at past instances where MRT's MACD turned positive, the stock continued to rise in 27 of 53 cases over the following month. The odds of a continued upward trend are 51%.
Following a +7.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where MRT advanced for three days, in 96 of 142 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
MRT moved below its 50-day moving average on September 29, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for MRT crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 59%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MRT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The Aroon Indicator for MRT entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-2.015) is normal, around the industry mean (-1.734). P/E Ratio (-3.900) is within average values for comparable stocks, (15.183). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.824). Dividend Yield (0.038) settles around the average of (0.074) among similar stocks. P/S Ratio (2.829) is also within normal values, averaging (71.128).
The Tickeron PE Growth Rating for this company is 46 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating fairly steady price growth. MRT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MRT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
HCAT | MRT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 77 | 87 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 42 Fair valued | 16 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 99 | 100 | |
PRICE GROWTH RATING 1..100 | 60 | 59 | |
P/E GROWTH RATING 1..100 | 20 | 46 | |
SEASONALITY SCORE 1..100 | n/a | 11 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MRT's Valuation (16) in the Real Estate Investment Trusts industry is in the same range as HCAT (42) in the null industry. This means that MRT’s stock grew similarly to HCAT’s over the last 12 months.
MRT's Profit vs Risk Rating (100) in the Real Estate Investment Trusts industry is in the same range as HCAT (100) in the null industry. This means that MRT’s stock grew similarly to HCAT’s over the last 12 months.
HCAT's SMR Rating (99) in the null industry is in the same range as MRT (100) in the Real Estate Investment Trusts industry. This means that HCAT’s stock grew similarly to MRT’s over the last 12 months.
MRT's Price Growth Rating (59) in the Real Estate Investment Trusts industry is in the same range as HCAT (60) in the null industry. This means that MRT’s stock grew similarly to HCAT’s over the last 12 months.
HCAT's P/E Growth Rating (20) in the null industry is in the same range as MRT (46) in the Real Estate Investment Trusts industry. This means that HCAT’s stock grew similarly to MRT’s over the last 12 months.
| HCAT | MRT | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 1 day ago 75% | 1 day ago 56% |
| Momentum ODDS (%) | 1 day ago 87% | 1 day ago 65% |
| MACD ODDS (%) | 1 day ago 86% | 1 day ago 51% |
| TrendWeek ODDS (%) | 1 day ago 87% | 1 day ago 49% |
| TrendMonth ODDS (%) | 1 day ago 88% | 1 day ago 67% |
| Advances ODDS (%) | 17 days ago 73% | 2 days ago 68% |
| Declines ODDS (%) | 4 days ago 87% | 15 days ago 78% |
| BollingerBands ODDS (%) | 1 day ago 85% | N/A |
| Aroon ODDS (%) | 1 day ago 89% | 1 day ago 81% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HCAT’s FA Score shows that 1 FA rating(s) are green while MRT’s FA Score has 1 green FA rating(s).
- HCAT’s FA Score: 1 green, 4 red.
- MRT’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HCAT’s TA Score shows that 4 TA indicator(s) are bullish while MRT’s TA Score has 5 bullish TA indicator(s).
- HCAT’s TA Score: 4 bullish, 6 bearish.
- MRT’s TA Score: 5 bullish, 4 bearish.
Price Growth
HCAT (@Services to the Health Industry) experienced а 0.00% price change this week, while MRT (@Packaged Software) price change was +10.17% for the same time period.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was -1.51%. For the same industry, the average monthly price growth was -3.63%, and the average quarterly price growth was +16.27%.
The average weekly price growth across all stocks in the @Packaged Software industry was -0.43%. For the same industry, the average monthly price growth was -3.98%, and the average quarterly price growth was +4.31%.
Reported Earning Dates
HCAT is expected to report earnings on Nov 09, 2026.
MRT is expected to report earnings on Nov 18, 2026.
Industries' Descriptions
@Services to the Health Industry (-1.51% weekly)This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
@Packaged Software (-0.43% weekly)Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.
Advertisement
HCAT and
Correlation & Price change
A.I.dvisor indicates that over the last year, HCAT has been loosely correlated with KVYO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HCAT jumps, then KVYO could also see price increases.
| Ticker / NAME | Correlation To HCAT | 1D Price Change % | ||
|---|---|---|---|---|
| HCAT | 100% | N/A | ||
| KVYO - HCAT | 47% Loosely correlated | +1.98% | ||
| EVCM - HCAT | 46% Loosely correlated | +0.22% | ||
| RDVT - HCAT | 45% Loosely correlated | -0.60% | ||
| CPAY - HCAT | 43% Loosely correlated | +1.83% | ||
| COIN - HCAT | 43% Loosely correlated | -4.51% | ||
More | ||||
MRT and
Correlation & Price change
A.I.dvisor indicates that over the last year, MRT has been loosely correlated with CYN. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if MRT jumps, then CYN could also see price increases.
| Ticker / NAME | Correlation To MRT | 1D Price Change % | ||
|---|---|---|---|---|
| MRT | 100% | -1.54% | ||
| CYN - MRT | 35% Loosely correlated | -1.95% | ||
| HCAT - MRT | 30% Poorly correlated | N/A | ||
| PAR - MRT | 27% Poorly correlated | +3.95% | ||
| PDFS - MRT | 27% Poorly correlated | -10.32% | ||
| DCBO - MRT | 26% Poorly correlated | +0.23% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BERZ | 21.12 | 2.35 | +12.52% |
| MicroSectors Solactive FANG & Innovation - 3X Inverse Leveraged ETN (BERZ) | |||
| XHE | 93.34 | 1.91 | +2.09% |
| State Street SPDR S&P Health Care Equipment ETF (XHE) | |||
| NEA | 10.14 | 0.18 | +1.81% |
| Nuveen AMT-Free Quality Municipal Income Fund | |||
| BDGS | 36.90 | -0.62 | -1.66% |
| Bridges Capital Tactical ETF (BDGS) | |||
| CVIE | 80.48 | -1.42 | -1.73% |
| Calvert International Responsible Index ETF (CVIE) | |||